Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines (Q38199151)

30 August 2017

title

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines (English)

1 reference

30 August 2017

Raquel P Deering

1

1 reference

30 August 2017

Sushma Kommareddy

2

1 reference

30 August 2017

Jeffrey B Ulmer

3

1 reference

30 August 2017

Luis A Brito

4

1 reference

30 August 2017

Andrew J Geall

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

26 March 2014

1 reference

Expert Opinion on Drug Delivery

30 August 2017

published in

1 reference

30 August 2017

volume

11

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

885-899

1 reference

Accelerating next-generation vaccine development for global disease prevention

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Immunologic basis of vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Clinical applications of DNA vaccines: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

DNA vaccines: an historical perspective and view to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

RNA: the new revolution in nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Vaccination with messenger RNA (mRNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Challenges and advances towards the rational design of mRNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

RNA-based vaccination: sending a strong message

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Synthetic antibodies for specific recognition and crystallization of structured RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Natural antibodies to nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Engineering dendritic cells to enhance cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Nonviral delivery of self-amplifying RNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Role of 5'- and 3'-untranslated regions of mRNAs in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

The implications of structured 5' untranslated regions on translation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Developing mRNA-vaccine technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Therapeutic and prophylactic applications of alphavirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Alphavirus vectors: applications for DNA vaccine production and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Alphavirus vectors: development and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Direct introduction of genes into rats and expression of the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Lipid-like materials for low-dose, in vivo gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

mRNA vaccination as a safe approach for specific protection from type I allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vivo gene delivery by nonviral vectors: overcoming hurdles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Viral and non-viral approaches for transient delivery of mRNA and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Nonviral, cationic lipid-mediated delivery of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Alphavirus vectors and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Mimicking live flavivirus immunization with a noninfectious RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Intradermal electroporation of naked replicon RNA elicits strong immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Artificial viruses: exploiting viral trafficking for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Recognition of viruses by cytoplasmic sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Pathogen recognition by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Antiviral signaling through pattern recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

TLR signalling and the function of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Efficient generation of human iPSCs by a synthetic self-replicative RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Virus membrane-fusion proteins: more than one way to make a hairpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Infection of cells by alphaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Alphavirus genome delivery occurs directly at the plasma membrane in a time- and temperature-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Conformational changes in Sindbis virions resulting from exposure to low pH and interactions with cells suggest that cell penetration may occur at the cell surface in the absence of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Virus entry: molecular mechanisms and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Biogenesis of the Semliki Forest virus RNA replication complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Single-particle tracking as a quantitative microscopy-based approach to unravel cell entry mechanisms of viruses and pharmaceutical nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Surveillance of siRNA integrity by FRET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Viral immune modulators perturb the human molecular network by common and unique strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Design opportunities for actively targeted nanoparticle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Tumor vaccination using messenger RNA: prospects of a future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

DNA vaccines: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Particle size and activation threshold: a new dimension of danger signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.901308

10.1517/17425247.2014.901308

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference